Control of excessive neural circuit excitability and prevention of epileptic seizures by endocannabinoid signaling

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Cellular and Molecular Life Sciences

• Publication date

  2018-05-08

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00018-018-2834-8PMID 29737364PMCID PMC11105219
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial.

  2018cited by this paper
• Rare genetic variants in the endocannabinoid system genes CNR1 and DAGLA are associated with neurological phenotypes in humans

  2017cited by this paper
• Fatty acid amide hydrolase inhibitor URB597 may protect against kainic acid-induced damage to hippocampal neurons: Dependence on the degree of injury.

  2017cited by this paper
• Trial of Cannabidiol for Drug‐Resistant Seizures in the Dravet Syndrome

  2017cited by this paper
• Cannabinoid receptor 1/2 double‐knockout mice develop epilepsy

  2017cited by this paper
• Low Frequency Electrical Stimulation Either Prior to Or after Rapid Kindling Stimulation Inhibits the Kindling-Induced Epileptogenesis

  2017cited by this paper
• Targeting brain and peripheral plasticity of the lipidome in acute kainic acid-induced epileptic seizures in mice via quantitative mass spectrometry.

  2017cited by this paper
• α/β-Hydrolase domain-containing 6 (ABHD6) negatively regulates the surface delivery and synaptic function of AMPA receptors

  2016cited by this paper
• Lipidomics profile of a NAPE-PLD KO mouse provides evidence of a broader role of this enzyme in lipid metabolism in the brain.

  2016cited by this paper
• Presynaptic Protein Synthesis Is Required for Long-Term Plasticity of GABA Release.

  2016cited by this paper
• Presynaptic inhibition upon CB1 or mGlu2/3 receptor activation requires ERK/MAPK phosphorylation of Munc18‐1

  2016cited by this paper
• The Differential Levels of Inflammatory Cytokines and BDNF among Bipolar Spectrum Disorders

  2016cited by this paper
• Cannabinoid Type 2 Receptors Mediate a Cell Type-Specific Plasticity in the Hippocampus.

  2016cited by this paper
• Deletion of CB2 cannabinoid receptors reduces synaptic transmission and long‐term potentiation in the mouse hippocampus

  2016cited by this paper
• Crucial Roles of the Endocannabinoid 2-Arachidonoylglycerol in the Suppression of Epileptic Seizures.

  2016cited by this paper
• The cannabinoid CB2 receptor-specific agonist AM1241 increases pentylenetetrazole-induced seizure severity in Wistar rats.

  2016cited by this paper
• Transient increase of interleukin-1β after prolonged febrile seizures promotes adult epileptogenesis through long-lasting upregulating endocannabinoid signaling

  2016cited by this paper
• Cannabinoids and Epilepsy

  2015cited by this paper
• Cannabinoid and nitric oxide signaling interplay in the modulation of hippocampal hyperexcitability: Study on electrophysiological and behavioral models of temporal lobe epilepsy in the rat.

  2015cited by this paper
• Cannabinoids in the Treatment of Epilepsy.

  2015cited by this paper
• Impaired 2-AG Signaling in Hippocampal Glutamatergic Neurons: Aggravation of Anxiety-Like Behavior and Unaltered Seizure Susceptibility

  2015cited by this paper
• Post-status epilepticus treatment with the cannabinoid agonist WIN 55,212-2 prevents chronic epileptic hippocampal damage in rats.

  2015cited by this paper
• Selective blockade of the hydrolysis of the endocannabinoid 2-arachidonoylglycerol impairs learning and memory performance while producing antinociceptive activity in rodents

  2015cited by this paper
• Inhibition of monoacylglycerol lipase mediates a cannabinoid 1-receptor dependent delay of kindling progression in mice.

  2015cited by this paper
• Palmitoylethanolamide attenuates PTZ-induced seizures through CB1 and CB2 receptors.

  2015cited by this paper
• Multiple Forms of Endocannabinoid and Endovanilloid Signaling Regulate the Tonic Control of GABA Release

  2015cited by this paper
• Analysis in conditional cannabinoid 1 receptor-knockout mice reveals neuronal subpopulation-specific effects on epileptogenesis in the kindling paradigm.

  2015cited by this paper
• Neuronal expression of CB2 cannabinoid receptor mRNAs in the mouse hippocampus.

  2015cited by this paper
• Weeding out bad waves: towards selective cannabinoid circuit control in epilepsy

  2015cited by this paper
• Cannabinoid CB2 receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice

  2014cited by this paper
• Distinct modulation of the endocannabinoid system upon kainic acid-induced in vivo seizures and in vitro epileptiform bursting.

  2014cited by this paper
• Enhanced excitatory synaptic network activity following transient group I metabotropic glutamate activation.

  2014cited by this paper
• Disease‐Modifying Effects of RHC80267 and JZL184 in a Pilocarpine Mouse Model of Temporal Lobe Epilepsy

  2014cited by this paper
• Modulation of Pilocarpine-Induced Seizures by Cannabinoid Receptor 1

  2014cited by this paper
• Role of CB2 receptors and cGMP pathway on the cannabinoid-dependent antiepileptic effects in an in vivo model of partial epilepsy.

  2014cited by this paper
• ABHD6 blockade exerts antiepileptic activity in PTZ-induced seizures and in spontaneous seizures in R6/2 mice.

  2014cited by this paper
• Astrocytic expression of cannabinoid type 1 receptor in rat and human sclerotic hippocampi.

  2014cited by this paper
• Prolonged Monoacylglycerol Lipase Blockade Causes Equivalent Cannabinoid Receptor Type 1 Receptor–Mediated Adaptations in Fatty Acid Amide Hydrolase Wild-Type and Knockout Mice

  2014cited by this paper
• Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy.

  2013cited by this paper
• Repeated Low-Dose Administration of the Monoacylglycerol Lipase Inhibitor JZL184 Retains Cannabinoid Receptor Type 1–Mediated Antinociceptive and Gastroprotective Effects

  2013cited by this paper
• Cannabinoid CB1 Receptor in Dorsal Telencephalic Glutamatergic Neurons: Distinctive Sufficiency for Hippocampus-Dependent and Amygdala-Dependent Synaptic and Behavioral Functions

  2013cited by this paper
• Voltage drives diverse endocannabinoid signals to mediate striatal microcircuit-specific plasticity

  2013cited by this paper
• Anandamide, Cannabinoid Type 1 Receptor, and NMDA Receptor Activation Mediate Non-Hebbian Presynaptically Expressed Long-Term Depression at the First Central Synapse for Visceral Afferent Fibers

  2013cited by this paper
• Neuron‐type specific cannabinoid‐mediated G protein signalling in mouse hippocampus

  2013cited by this paper
• Effects of cannabinoids and endocannabinoid hydrolysis inhibition on pentylenetetrazole-induced seizure and electroencephalographic activity in rats.

  2013cited by this paper
• Acute cannabinoids impair working memory through astroglial CB1 receptor modulation of hippocampal LTD.

  2012cited by this paper
• Neuroprotective agents: cannabinoids.

  2012cited by this paper
• Anandamide and 2-arachidonoylglycerol: Pharmacological Properties, Functional Features, and Emerging Specificities of the Two Major Endocannabinoids

  2012cited by this paper
• Endocannabinoids and Retrograde Modulation of Synaptic Transmission

  2012cited by this paper
• Neuron NeuroResource High-Resolution Proteomics Unravel Architecture and Molecular Diversity of Native AMPA Receptor Complexes

  2012cited by this paper
• Synapse type-independent degradation of the endocannabinoid 2-arachidonoylglycerol after retrograde synaptic suppression

  2012cited by this paper
• Intrinsic Up-Regulation of 2-AG Favors an Area Specific Neuronal Survival in Different In Vitro Models of Neuronal Damage

  2012cited by this paper
• Endocannabinoid signaling and synaptic function.

  2012cited by this paper
• Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia

  2012cited by this paper
• Patterns of treatment response in newly diagnosed epilepsy

  2012cited by this paper
• Involvement of transient receptor potential vanilloid type 1 channels in the pro-convulsant effect of anandamide in pentylenetetrazole-induced seizures.

  2012cited by this paper
• The major central endocannabinoid directly acts at GABAA receptors

  2011cited by this paper
• Non‐psychoactive cannabinoids modulate the descending pathway of antinociception in anaesthetized rats through several mechanisms of action

  2011cited by this paper
• Modulation of Anticonvulsant Effects of Cannabinoid Compounds by GABA-A Receptor Agonist in Acute Pentylenetetrazole Model of Seizure in Rat

  2011cited by this paper
• Alterations of Endocannabinoid Signaling, Synaptic Plasticity, Learning, and Memory in Monoacylglycerol Lipase Knock-out Mice

  2011cited by this paper
• Incidence of epilepsy

  2011cited by this paper
• Pharmacological Activation of Kainate Receptors Drives Endocannabinoid Mobilization

  2011cited by this paper
• In vivo activation of endocannabinoid system in temporal lobe epilepsy with hippocampal sclerosis.

  2011cited by this paper
• Molecular and Morphological Configuration for 2-Arachidonoylglycerol-Mediated Retrograde Signaling at Mossy Cell–Granule Cell Synapses in the Dentate Gyrus

  2011cited by this paper
• Targeting the endocannabinoid system in the amygdala kindling model of temporal lobe epilepsy in mice

  2011cited by this paper
• Peripherally acting CB1-receptor antagonist: the relative importance of central and peripheral CB1 receptors in adiposity control

  2010cited by this paper
• Genetic susceptibility to febrile seizures: case-control association studies.

  2010cited by this paper
• The endocannabinoid 2-arachidonoylglycerol produced by diacylglycerol lipase alpha mediates retrograde suppression of synaptic transmission.

  2010cited by this paper
• AAV Vector-Mediated Overexpression of CB1 Cannabinoid Receptor in Pyramidal Neurons of the Hippocampus Protects against Seizure-Induced Excitoxicity

  2010cited by this paper
• Loss of Retrograde Endocannabinoid Signaling and Reduced Adult Neurogenesis in Diacylglycerol Lipase Knock-out Mice

  2010cited by this paper
• Peripherally acting CB1-receptor antagonist: the relative importance of central and peripheral CB1 receptors in adiposity control

  2010cited by this paper
• Postsynaptic TRPV1 triggers cell type–specific long-term depression in the nucleus accumbens

  2010cited by this paper
• Cerebrospinal fluid levels of the endocannabinoid anandamide are reduced in patients with untreated newly diagnosed temporal lobe epilepsy

  2010cited by this paper
• TRPV1 activation by endogenous anandamide triggers postsynaptic LTD in dentate gyrus

  2010cited by this paper
• Dynamic changes of CB1‐receptor expression in hippocampi of epileptic mice and humans

  2010cited by this paper
• Endocannabinoid signaling and long-term synaptic plasticity.

  2009cited by this paper
• Long-term risk of epilepsy after traumatic brain injury in children and young adults: a population-based cohort study.

  2009cited by this paper
• Prolonged exposure to WIN55,212-2 causes downregulation of the CB1 receptor and the development of tolerance to its anticonvulsant effects in the hippocampal neuronal culture model of acquired epilepsy.

  2009cited by this paper
• Temporal characterization of changes in hippocampal cannabinoid CB(1) receptor expression following pilocarpine-induced status epilepticus.

  2009cited by this paper
• Evidences of cannabinoids-induced modulation of paroxysmal events in an experimental model of partial epilepsy in the rat.

  2009cited by this paper
• Single application of a CB1 receptor antagonist rapidly following head injury prevents long-term hyperexcitability in a rat model.

  2009cited by this paper
• Ketogenic diet is antiepileptogenic in pentylenetetrazole kindled mice and decrease levels of N-acylethanolamines in hippocampus.

  2009cited by this paper
• Endocannabinoid-mediated control of synaptic transmission.

  2009cited by this paper
• Interneuron activity controls endocannabinoid-mediated presynaptic plasticity through calcineurin

  2008cited by this paper
• Regulation of excitability and plasticity by endocannabinoids and PKA in developing hippocampus

  2008cited by this paper
• Downregulation of the CB1 Cannabinoid Receptor and Related Molecular Elements of the Endocannabinoid System in Epileptic Human Hippocampus

  2008cited by this paper
• Dose-Related Differences in the Regional Pattern of Cannabinoid Receptor Adaptation and in Vivo Tolerance Development to Δ9-Tetrahydrocannabinol

  2008cited by this paper
• Endocannabinoid signaling as a synaptic circuit breaker in neurological disease

  2008cited by this paper
• Cannabinoid CB1 receptor antagonists cause status epilepticus-like activity in the hippocampal neuronal culture model of acquired epilepsy.

  2007cited by this paper
• Endocannabinoid signalling triggered by NMDA receptor‐mediated calcium entry into rat hippocampal neurons

  2007cited by this paper
• Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro

  2007cited by this paper
• Endocannabinoid Enhancement Protects against Kainic Acid-Induced Seizures and Associated Brain Damage

  2007cited by this paper
• Drug treatments for obesity: orlistat, sibutramine, and rimonabant.

  2007cited by this paper
• A Comprehensive Profile of Brain Enzymes that Hydrolyze the Endocannabinoid 2‐Arachidonoylglycerol

  2007cited by this paper
• Prevention of Plasticity of Endocannabinoid Signaling Inhibits Persistent Limbic Hyperexcitability Caused by Developmental Seizures

  2007cited by this paper
• Ca(2+)-assisted receptor-driven endocannabinoid release: mechanisms that associate presynaptic and postsynaptic activities.

  2007cited by this paper
• Endocannabinoid-mediated long-term plasticity requires cAMP/PKA signaling and RIM1alpha.

  2007cited by this paper
• Status epilepticus causes a long-lasting redistribution of hippocampal cannabinoid type 1 receptor expression and function in the rat pilocarpine model of acquired epilepsy.

  2007cited by this paper
• Prolonged Recovery Rate of CB1 Receptor Adaptation after Cessation of Long-Term Cannabinoid Administration

  2006cited by this paper
• Activation of the Cannabinoid Type-1 Receptor Mediates the Anticonvulsant Properties of Cannabinoids in the Hippocampal Neuronal Culture Models of Acquired Epilepsy and Status Epilepticus

  2006cited by this paper

• Dysregulation of the Cannabinoid System in Childhood Epilepsy: From Mechanisms to Therapy

  2025cites this paper
• Brain connectivity regions of lesions causing focal to bilateral tonic-clonic seizures correlates with gene expression

  2025cites this paper
• Endocannabinoid signaling in epilepsy.

  2025cites this paper
• Binding of the monoacylglycerol lipase (MAGL) radiotracer [3H]T-401 in the rat brain after status epilepticus.

  2024cites this paper
• Increased hippocampal cannabinoid 1 receptor expression is associated with protection from severe seizures in pregnant mice with reduced uterine perfusion pressure

  2023cites this paper
• Phytocannabinoids Reduce Seizures in Larval Zebrafish and Affect Endocannabinoid Gene Expression

  2023cites this paper
• Hippocampal expression of the cannabinoid receptor type 1 in canine epilepsy

  2023cites this paper
• CBD can be combined with additional cannabinoids for optimal seizure reduction and requires GPR55 for its anticonvulsant effects

  2023cites this paper
• 2-AG-Mediated Control of GABAergic Signaling Is Impaired in a Model of Epilepsy

  2022influential citation
• Hyperthermia-Induced Seizures Enhance Brain Concentrations of the Endocannabinoid-Related Linoleoyl Glycerols in a Scn1a+/− Mouse Model of Dravet Syndrome

  2022cites this paper
• Endocannabinoid-Mediated Control of Neural Circuit Excitability and Epileptic Seizures

  2022cites this paper
• The Endocannabinoid System in Glial Cells and Their Profitable Interactions to Treat Epilepsy: Evidence from Animal Models

  2021cites this paper
• The Neuroprotective properties, Functions and Roles of Cannabis sativa in selected diseases related to the Nervous System.

  2021cites this paper
• Endocannabinoid-serotonin systems interaction in health and disease.

  2021cites this paper
• From an Alternative Medicine to a New Treatment for Refractory Epilepsies: Can Cannabidiol Follow the Same Path to Treat Neuropsychiatric Disorders?

  2021cites this paper
• Therapeutic potential of cannabidivarin for epilepsy and autism spectrum disorder.

  2021cites this paper
• Mechanisms of endocannabinoid control of synaptic plasticity.

  2021cites this paper
• Investigation on the active ingredient and mechanism of Cannabis sativa L. for treating epilepsy based on network pharmacology

  2021cites this paper
• Channelopathy of Dravet Syndrome and Potential Neuroprotective Effects of Cannabidiol

  2021cites this paper
• Fatty Acid Amides Synthesized from Andiroba Oil (Carapa guianensis Aublet.) Exhibit Anticonvulsant Action with Modulation on GABA-A Receptor in Mice: A Putative Therapeutic Option

  2020influential citation
• Bench to bedside: multiple facets of cannabinoid control in epilepsy.

  2020cites this paper
• HIV Tat Protein Selectively Impairs CB1 Receptor-Mediated Presynaptic Inhibition at Excitatory But Not Inhibitory Synapses

  2020cites this paper
• The Participation of Endocannabinoid Receptors in the Regulation of Spontaneous Synaptic Activity at Neuromuscular Junctions of Mice

  2020cites this paper
• Cannabis for Pediatric Epilepsy.

  2020cites this paper
• Cannabis for Pediatric and Adult Epilepsy

  2019cites this paper
• Cannabinoids, TRPV and nitric oxide: the three ring circus of neuronal excitability

  2019cites this paper